A global network for network medicine
- PMID: 32868765
- PMCID: PMC7459285
- DOI: 10.1038/s41540-020-00143-9
A global network for network medicine
Abstract
Network Medicine is now an established scientific discipline, having generated key insights on integrated mechanisms underlying complex human diseases. The next discovery phase will emphasize innovating analytics that optimize networks for advancing precision medicine. Accomplishing this goal will require organizing a scientifically diverse team studying big datasets shared globally.
Conflict of interest statement
B.A.M.: Consultant for Actelion Pharmaceuticals for a project unrelated to this current work; co-inventor on U.S. patent pending PCT/US2019/059890 and U.S. patent 9,605,047, which are not related to the current work. P.F.: Founder and CEO of Pharmahungary Group, a group of R&D companies. E.S.: In the past 3 years, he has received institutional grant support from GSK and Bayer. A.L.B.: is the founder of Scipher, Foodome and Nomix, companies that are using tools of network science to make an impact on health. J.L.: Co-founder of Scipher (for profit) Scientific Advisory Board (2013-to present), and consulting services. The remaining authors declare no competing interests.
References
MeSH terms
LinkOut - more resources
Full Text Sources
